CN104721807A - Oral liquid for treating psoriasis - Google Patents
Oral liquid for treating psoriasis Download PDFInfo
- Publication number
- CN104721807A CN104721807A CN201510171391.8A CN201510171391A CN104721807A CN 104721807 A CN104721807 A CN 104721807A CN 201510171391 A CN201510171391 A CN 201510171391A CN 104721807 A CN104721807 A CN 104721807A
- Authority
- CN
- China
- Prior art keywords
- oral liquid
- parts
- lien
- caprae seu
- seu ovis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses oral liquid for treating psoriasis, comprising, by weight, 8 to 15 parts of sheep spleen polypeptides, 10 to 30 parts of mung bean, 2 to 5 parts of Sichuan pepper, 6 to 20 parts of pseudo-ginseng and 500 to 800 parts of water. The oral liquid is made by means of crushing, water-extracting, concentrating, mixing and packaging and sterilizing. The oral liquid made of natural materials of homology of medicine and food is mainly made from the mung bean, with the sheep spleen polypeptides, the Sichuan pepper and the pseudo-ginseng; by scientific matching, the oral liquid is made, having the effects such as clearing heat and damp, stopping itch and promoting granulation, killing germs and enhancing immunity; the clinical application of the oral liquid in treatment of psoriasis shows that curate is 87% and effective rate is up to 99%. The oral liquid has the advantages such that the course of treatment is short, effect is evident, cure rate is high, no reoccurrence occurs after curing, the oral liquid is convenient to consume, has low allergy rate and has no toxic or side effects; the oral liquid further has the advantages that the preparing process is simple, the range of materials is wide and the cost is low.
Description
Technical field
The present invention relates to technical field of traditional Chinese medicine pharmacy, specifically one treats psoriatic oral liquid.
Background technology
Psoriasis, also known as Bai Mange, psoriasis, psoriasis is that a kind of common chronic inflammatory skin is sick.Onset of psoriasis reason is many attacks skin by wind, cold, wet, heat, dry, malicious heresy, and ferritic heat in blood, eating and drinking without temperance, feelings will internal injury causes skin disharmony of nutrient QI with defensive QI, disharmony between QI and blood, and QI and blood microcirculation is obstructed, and the stasis of blood forms in flesh table.The feature that psoriasis has long, the easy recurrence of the course of disease, refractory is healed.Current Therapeutic Method has steroid hormone method to treat, suppresses DNA class medicine, antitumor drug, immune formulation, interferon therapy etc., but these methods have serious side effect, or expensive, is unfavorable for Rehabilitation and selects.
Summary of the invention
The object of the present invention is to provide one to treat psoriatic oral liquid, there is short treating period, evident in efficacy, cure rate is high, more after do not recur, mild in medicine property and, the advantage such as irritated rate is low, have no side effect.
For achieving the above object, the invention provides following technical scheme:
One treats psoriatic oral liquid, and raw material by weight comprises Lien Caprae seu ovis polypeptide 8-15 part, Semen phaseoli radiati 10-30 part, Pericarpium Zanthoxyli 2-5 part, Radix Notoginseng 6-20 part and water 500-800 part.
As the further scheme of the present invention: raw material by weight comprises Lien Caprae seu ovis polypeptide 10-13 part, Semen phaseoli radiati 15-22 part, Pericarpium Zanthoxyli 3-5 part, Radix Notoginseng 10-20 part and water 500-600 part.
As the further scheme of the present invention: raw material by weight comprises Lien Caprae seu ovis polypeptide 10 parts, 20 parts, Semen phaseoli radiati, 4 parts, Pericarpium Zanthoxyli, Radix Notoginseng 15 parts and 600 parts, water.
The preparation method of the psoriatic oral liquid of described treatment, comprises the following steps:
(1) take Lien Caprae seu ovis polypeptide, Semen phaseoli radiati, Pericarpium Zanthoxyli, Radix Notoginseng and water according to weight portion, Lien Caprae seu ovis polypeptide is pulverized, cross 200-300 mesh sieve, obtain Lien Caprae seu ovis polypeptide powder, for subsequent use;
(2) Pericarpium Zanthoxyli and panax mixed is even, then add the 50-70% of total Water, intense fire boils, and slow fire insulation 10-20 minute, filters and obtain filtrate and filtering residue, for subsequent use;
(3) in the filtering residue of step (2), add remaining water, intense fire boils, then adds Semen phaseoli radiati, and slow fire insulation 3-5 minute, filters and obtain filtrate, for subsequent use;
(4) twice filtrate is merged, be concentrated into the volume of half, obtain concentrated solution;
(5) add in concentrated solution by the Lien Caprae seu ovis polypeptide powder of step (1), mix homogeneously, obtains mixed liquor;
(6) by mixed liquor subpackage, sealing, sterilization treatment, must treat psoriatic oral liquid.
The psoriatic oral liquid of described treatment is applied in psoriatic treatment.
Compared with prior art, the invention has the beneficial effects as follows: the present invention adopts the raw material of natural integration of edible and medicinal herbs, based on Semen phaseoli radiati, coordinate Lien Caprae seu ovis polypeptide, Pericarpium Zanthoxyli and Radix Notoginseng, through scientific compatibility, obtained a kind of oral liquid having the effect such as clearing heat and expelling damp, antipruritic effect and promoting granulation, sterilization, enhancing immunity, be applied in psoriatic treatment, through clinical practice checking, cure rate is 87%, and effective percentage is up to 99%.The present invention has short treating period, evident in efficacy, cure rate is high, more after do not recur, taking convenience, mild in medicine property and, the advantage such as irritated rate is low, have no side effect.Preparation technology of the present invention is simple, has the advantages that raw material sources are wide, cost is low.
Detailed description of the invention
Below in conjunction with the embodiment of the present invention, be clearly and completely described the technical scheme in the embodiment of the present invention, obviously, described embodiment is only the present invention's part embodiment, instead of whole embodiments.Based on the embodiment in the present invention, those of ordinary skill in the art, not making the every other embodiment obtained under creative work prerequisite, belong to the scope of protection of the invention.
Embodiment 1
In the embodiment of the present invention, one treats psoriatic oral liquid, and raw material by weight comprises Lien Caprae seu ovis polypeptide 8 parts, 25 parts, Semen phaseoli radiati, 3 parts, Pericarpium Zanthoxyli, Radix Notoginseng 10 parts and 500 parts, water.
The preparation method of the psoriatic oral liquid of described treatment, comprises the following steps:
(1) take Lien Caprae seu ovis polypeptide, Semen phaseoli radiati, Pericarpium Zanthoxyli, Radix Notoginseng and water according to weight portion, Lien Caprae seu ovis polypeptide is pulverized, cross 200 mesh sieves, obtain Lien Caprae seu ovis polypeptide powder, for subsequent use;
(2) Pericarpium Zanthoxyli and panax mixed is even, then add 50% of total Water, intense fire boils, and slow fire is incubated 20 minutes, filters and obtains filtrate and filtering residue, for subsequent use;
(3) in the filtering residue of step (2), add remaining water, intense fire boils, then adds Semen phaseoli radiati, and slow fire is incubated 3 minutes, filters and obtains filtrate, for subsequent use;
(4) twice filtrate is merged, be concentrated into the volume of half, obtain concentrated solution;
(5) add in concentrated solution by the Lien Caprae seu ovis polypeptide powder of step (1), mix homogeneously, obtains mixed liquor;
(6) by mixed liquor subpackage, sealing, sterilization treatment, must treat psoriatic oral liquid.
Embodiment 2
In the embodiment of the present invention, one treats psoriatic oral liquid, and raw material by weight comprises Lien Caprae seu ovis polypeptide 10 parts, 20 parts, Semen phaseoli radiati, 4 parts, Pericarpium Zanthoxyli, Radix Notoginseng 15 parts and 600 parts, water.
The preparation method of the psoriatic oral liquid of described treatment, comprises the following steps:
(1) take Lien Caprae seu ovis polypeptide, Semen phaseoli radiati, Pericarpium Zanthoxyli, Radix Notoginseng and water according to weight portion, Lien Caprae seu ovis polypeptide is pulverized, cross 300 mesh sieves, obtain Lien Caprae seu ovis polypeptide powder, for subsequent use;
(2) Pericarpium Zanthoxyli and panax mixed is even, then add 60% of total Water, intense fire boils, and slow fire is incubated 15 minutes, filters and obtains filtrate and filtering residue, for subsequent use;
(3) in the filtering residue of step (2), add remaining water, intense fire boils, then adds Semen phaseoli radiati, and slow fire is incubated 4 minutes, filters and obtains filtrate, for subsequent use;
(4) twice filtrate is merged, be concentrated into the volume of half, obtain concentrated solution;
(5) add in concentrated solution by the Lien Caprae seu ovis polypeptide powder of step (1), mix homogeneously, obtains mixed liquor;
(6) by mixed liquor subpackage, sealing, sterilization treatment, must treat psoriatic oral liquid.
Embodiment 3
In the embodiment of the present invention, one treats psoriatic oral liquid, and raw material by weight comprises Lien Caprae seu ovis polypeptide 12 parts, 30 parts, Semen phaseoli radiati, 5 parts, Pericarpium Zanthoxyli, Radix Notoginseng 12 parts and 800 parts, water.
The preparation method of the psoriatic oral liquid of described treatment, comprises the following steps:
(1) take Lien Caprae seu ovis polypeptide, Semen phaseoli radiati, Pericarpium Zanthoxyli, Radix Notoginseng and water according to weight portion, Lien Caprae seu ovis polypeptide is pulverized, cross 250 mesh sieves, obtain Lien Caprae seu ovis polypeptide powder, for subsequent use;
(2) Pericarpium Zanthoxyli and panax mixed is even, then add 70% of total Water, intense fire boils, and slow fire is incubated 10 minutes, filters and obtains filtrate and filtering residue, for subsequent use;
(3) in the filtering residue of step (2), add remaining water, intense fire boils, then adds Semen phaseoli radiati, and slow fire is incubated 5 minutes, filters and obtains filtrate, for subsequent use;
(4) twice filtrate is merged, be concentrated into the volume of half, obtain concentrated solution;
(5) add in concentrated solution by the Lien Caprae seu ovis polypeptide powder of step (1), mix homogeneously, obtains mixed liquor;
(6) by mixed liquor subpackage, sealing, sterilization treatment, must treat psoriatic oral liquid.
Embodiment 4
In the embodiment of the present invention, one treats psoriatic oral liquid, and raw material by weight comprises Lien Caprae seu ovis polypeptide 13 parts, 15 parts, Semen phaseoli radiati, 2 parts, Pericarpium Zanthoxyli, Radix Notoginseng 20 parts and 600 parts, water.
The preparation method of the psoriatic oral liquid of described treatment, comprises the following steps:
(1) take Lien Caprae seu ovis polypeptide, Semen phaseoli radiati, Pericarpium Zanthoxyli, Radix Notoginseng and water according to weight portion, Lien Caprae seu ovis polypeptide is pulverized, cross 300 mesh sieves, obtain Lien Caprae seu ovis polypeptide powder, for subsequent use;
(2) Pericarpium Zanthoxyli and panax mixed is even, then add 55% of total Water, intense fire boils, and slow fire is incubated 15 minutes, filters and obtains filtrate and filtering residue, for subsequent use;
(3) in the filtering residue of step (2), add remaining water, intense fire boils, then adds Semen phaseoli radiati, and slow fire is incubated 5 minutes, filters and obtains filtrate, for subsequent use;
(4) twice filtrate is merged, be concentrated into the volume of half, obtain concentrated solution;
(5) add in concentrated solution by the Lien Caprae seu ovis polypeptide powder of step (1), mix homogeneously, obtains mixed liquor;
(6) by mixed liquor subpackage, sealing, sterilization treatment, must treat psoriatic oral liquid.
Embodiment 5
In the embodiment of the present invention, one treats psoriatic oral liquid, and raw material by weight comprises Lien Caprae seu ovis polypeptide 15 parts, 10 parts, Semen phaseoli radiati, 4 parts, Pericarpium Zanthoxyli, Radix Notoginseng 6 parts and 700 parts, water.
The preparation method of the psoriatic oral liquid of described treatment, comprises the following steps:
(1) take Lien Caprae seu ovis polypeptide, Semen phaseoli radiati, Pericarpium Zanthoxyli, Radix Notoginseng and water according to weight portion, Lien Caprae seu ovis polypeptide is pulverized, cross 250 mesh sieves, obtain Lien Caprae seu ovis polypeptide powder, for subsequent use;
(2) Pericarpium Zanthoxyli and panax mixed is even, then add 65% of total Water, intense fire boils, and slow fire is incubated 20 minutes, filters and obtains filtrate and filtering residue, for subsequent use;
(3) in the filtering residue of step (2), add remaining water, intense fire boils, then adds Semen phaseoli radiati, and slow fire is incubated 3 minutes, filters and obtains filtrate, for subsequent use;
(4) twice filtrate is merged, be concentrated into the volume of half, obtain concentrated solution;
(5) add in concentrated solution by the Lien Caprae seu ovis polypeptide powder of step (1), mix homogeneously, obtains mixed liquor;
(6) by mixed liquor subpackage, sealing, sterilization treatment, must treat psoriatic oral liquid.
The property of medicine and the effect of each raw material of the present invention are as follows:
Semen phaseoli radiati is traditional bean food of our people.The mineral such as the multivitamin in Semen phaseoli radiati, calcium, phosphorus, ferrum are all many than Semen oryzae sativae, nutritious because of it, can make bean medicated porridge, bean meal, bean wine, food, Chao food, or pause cake as bait, or germinate and cook, therefore have the title of " in food good merchantable brand, long paddy of benefiting mankind ".The protein 22-26% contained in Semen phaseoli radiati, it is 2.3 times of Semen Tritici aestivi flour, 2.7 times of Semen setariae, three times of Semen Maydis flour, 3.2 times of rice, in Semen phaseoli radiati albumen matter, the content of necessary 8 seed amino acids of human body is 2 ~ 5 times of Cereal, is wherein rich in the complete protein of aminoacid, tryptophan, lysine, leucine, threonine.Therefore, by Semen phaseoli radiati and rice, Semen setariae is matched, and aminoacid can be made complementary; Containing starch about 50% in Semen phaseoli radiati, be only second to Cereal, wherein amylose accounts for 29%, and amylopectin accounts for 71%.In Semen phaseoli radiati, content of cellulose is higher, and generally at 3-4%, and Cereal only has 1-2%.In Semen phaseoli radiati, fat content is lower, generally below 1%, and mainly palmitic acid, the unsaturated fatty acids such as linoleic acid plus linolenic acid.Semen phaseoli radiati contains the nutritional labelings such as abundant vitamin B group, mineral.Wherein vitamin B1 is 17.5 times of Carnis Gallus domesticus; Vitamin B2 be the 2-4 of Cereal doubly, and higher than Carnis Sus domestica, milk, Carnis Gallus domesticus, fish, calcium is 4 times of Cereal, 7 times of Carnis Gallus domesticus, and ferrum is 4 times of Carnis Gallus domesticus, phosphorus be Cereal and Carnis Sus domestica, Carnis Gallus domesticus, fish, 2 times of egg.Semen phaseoli radiati contains the phospholipid of multiple needed by human body.Numerous bioactive substances contained by Semen phaseoli radiati are as coumarin, alkaloid, plant sterol, Saponin etc.
Semen phaseoli radiati, cold in nature, sweet in the mouth, enters the heart, stomach warp, has heat-clearing and toxic substances removing, the effect of relieving summer heat.For summer-heat excessive thirst, the diseases such as sore carbuncle.Compendium of Material Medica cloud: " Semen phaseoli radiati though the merit of detumescence treatment of smallpox is same as Semen Phaseoli, and presses the power of thermal detoxification to cross it.And QI invigorating, thick the intestines and stomach, qualcomm meridian, without taking avoiding of withered people for a long time.Surgery controls carbuncle, and have expelling the toxic substance from the body with tonic to protect the heart and fall apart, pole says that it is imitated." and " metal and stone, arsenicum, all poison of vegetation can be separated ".
Lien Caprae seu ovis polypeptide, obtained through steps such as degrease, homogenate, acid adjustment, freeze thawing fragmentation, adjust ph precipitation, heating, centrifugal filtration, ultrafiltration by the spleen tissue of healthy lamb, dual regulation is had to body's immunity, can rectifier body immunity function disorderly, there is the effect of activation and enhancing body non-specific immunity, T lymphocyte maturation can be promoted and non-primed lymphocyte can be made to activate to become primed lymphocyte, thus raising lymphocyte immunologic function, triggering and enhancing body are to the resistance infected; Also can inducement interferon, directly stop the synthesis of virus protein and copy, and cell surface antigen can be strengthened express, promote the cytotoxic activity of NK cell, regulate the function of lymphocyte and macrophage, obviously can improve Immune Function; Can proliferation of bone marrow cells be stimulated, produce a large amount of leukocyte, hemopoietic function is improved.
Pericarpium Zanthoxyli, warm in nature, acrid in the mouth, returns spleen, stomach, kidney channel, has warming middle-JIAO to relieve pain, effect of killing parasites for relieving itching.For coldness and pain in the epigastrium, vomiting is had loose bowels, abdominal pain due to worm stagnation, ascariasis; External treatment eczema pruritus.
Radix Notoginseng, warm in nature, sweet in the mouth, micro-hardship, return liver, stomach warp, has dissipating blood stasis hemostasis, effect of subduing swelling and relieving pain.For spitting of blood, spit blood, epistaxis, has blood in stool, metrorrhagia, traumatic hemorrhage, and breast abdomen twinges, tumbling and swelling.
The present invention is based on Chinese traditional treatment with the removing heat from blood that detoxifies, dispersing swelling and dissipating binds, clearing heat and moistening dryness, the QI invigorating that nourishes blood, relaxing muscles and tendons and activating QI and blood in the collateral and enhancing immunity for means, with QI and blood regulating, recovery body homergy, reach and effectively treat psoriasis and the effect preventing recurrence.Usage of the present invention and consumption are: every day sooner or later each once, each serving with 2ml, the person of being in a bad way is each serving with doubling dosage.
Animal acute toxicity test is carried out to foregoing invention embodiment, get Mouse and rat half and half, be divided into 5 groups, wherein first group of oral medicine of the present invention giving embodiment 1 preparation of 5ml/kg, medicine of the present invention prepared by second group of oral embodiment 2 giving 5ml/kg, medicine of the present invention prepared by the 3rd group of oral embodiment 3 giving 5ml/kg, medicine of the present invention prepared by the 4th group of oral embodiment 4 giving 5ml/kg, medicine of the present invention prepared by the 5th group of oral embodiment 5 giving 5ml/kg, once a day, 7 days are continued.To observation post administration 2 weeks, there is no dead mouse.The test dose adopted in animal acute toxicity test is all greater than more than 20 times of people's oral dose every day, and the toxicity that result shows this medicine is very micro-.Therefore, clinical trial is carried out to being diagnosed as psoriatic patient.
In clinical trial, the routine patient of random selecting 100, takes medicine of the present invention, and after medication two weeks, healing 87 is routine and without recurrence, effective 4 examples, take a turn for the better 8 examples.Of the present invention evident in efficacy, effective percentage is up to 99%, and cure rate is 87%.
Model case
1, Zhang, female, 43 years old, suffer from psoriasis 12 years, originally there is a small amount of erythema in whole body, and pruritus is not obvious; Erythema increased gradually afterwards, and substrate infiltrates obviously, and skin lesion surface coverage has multilamellar silvery white squama, and easily strike off, pruritus is hard to bear.After taking one week of oral liquid of the present invention, squama obviously reduces, and pruritus also alleviates to some extent, and after continuing to take two weeks, erythema disappears, and squama disappears, and other malaise symptoms all disappear, and fully recover.Follow up a case by regular visits to half a year without recurrence.
2, Lee, man, 29 years old, suffer from psoriasis more than a year, initial total body flush, skin surface has white scales to come off, and with pruritus, multi-treatment is all invalid.After taking one week of oral liquid of the present invention, white scales obviously reduces, and pruritus alleviates to some extent, and after continuing to take one week, white scales disappears, and other malaise symptoms all disappear, and fully recover.Follow up a case by regular visits to half a year without recurrence.
To those skilled in the art, obviously the invention is not restricted to the details of above-mentioned one exemplary embodiment, and when not deviating from spirit of the present invention or basic feature, the present invention can be realized in other specific forms.Therefore, no matter from which point, all should embodiment be regarded as exemplary, and be nonrestrictive, scope of the present invention is limited by claims instead of above-mentioned explanation, and all changes be therefore intended in the implication of the equivalency by dropping on claim and scope are included in the present invention.
In addition, be to be understood that, although this description is described according to embodiment, but not each embodiment only comprises an independently technical scheme, this narrating mode of description is only for clarity sake, those skilled in the art should by description integrally, and the technical scheme in each embodiment also through appropriately combined, can form other embodiments that it will be appreciated by those skilled in the art that.
Claims (5)
1. treat a psoriatic oral liquid, it is characterized in that, raw material by weight comprises Lien Caprae seu ovis polypeptide 8-15 part, Semen phaseoli radiati 10-30 part, Pericarpium Zanthoxyli 2-5 part, Radix Notoginseng 6-20 part and water 500-800 part.
2. the psoriatic oral liquid for the treatment of according to claim 1, is characterized in that, raw material by weight comprises Lien Caprae seu ovis polypeptide 10-13 part, Semen phaseoli radiati 15-22 part, Pericarpium Zanthoxyli 3-5 part, Radix Notoginseng 10-20 part and water 500-600 part.
3. the psoriatic oral liquid for the treatment of according to claim 1, is characterized in that, raw material by weight comprises Lien Caprae seu ovis polypeptide 10 parts, 20 parts, Semen phaseoli radiati, 4 parts, Pericarpium Zanthoxyli, Radix Notoginseng 15 parts and 600 parts, water.
4. a preparation method for the psoriatic oral liquid for the treatment of as described in as arbitrary in claim 1-3, is characterized in that, comprise the following steps:
(1) take Lien Caprae seu ovis polypeptide, Semen phaseoli radiati, Pericarpium Zanthoxyli, Radix Notoginseng and water according to weight portion, Lien Caprae seu ovis polypeptide is pulverized, cross 200-300 mesh sieve, obtain Lien Caprae seu ovis polypeptide powder, for subsequent use;
(2) Pericarpium Zanthoxyli and panax mixed is even, then add the 50-70% of total Water, intense fire boils, and slow fire insulation 10-20 minute, filters and obtain filtrate and filtering residue, for subsequent use;
(3) in the filtering residue of step (2), add remaining water, intense fire boils, then adds Semen phaseoli radiati, and slow fire insulation 3-5 minute, filters and obtain filtrate, for subsequent use;
(4) twice filtrate is merged, be concentrated into the volume of half, obtain concentrated solution;
(5) add in concentrated solution by the Lien Caprae seu ovis polypeptide powder of step (1), mix homogeneously, obtains mixed liquor;
(6) by mixed liquor subpackage, sealing, sterilization treatment, must treat psoriatic oral liquid.
5. the psoriatic oral liquid for the treatment of according to claim 1 is applied in psoriatic treatment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510171391.8A CN104721807A (en) | 2015-04-13 | 2015-04-13 | Oral liquid for treating psoriasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510171391.8A CN104721807A (en) | 2015-04-13 | 2015-04-13 | Oral liquid for treating psoriasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104721807A true CN104721807A (en) | 2015-06-24 |
Family
ID=53446603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510171391.8A Pending CN104721807A (en) | 2015-04-13 | 2015-04-13 | Oral liquid for treating psoriasis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104721807A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1019400B (en) * | 1985-07-22 | 1992-12-09 | 三和化工株式会社 | Method for manufacture of polyolefin foam |
| CN1259523A (en) * | 1999-08-31 | 2000-07-12 | 中国人民解放军空军总医院 | Immuno active polypeptide for treating psoriasis and its prepn. method |
| CN1319400A (en) * | 2001-02-28 | 2001-10-31 | 中国人民解放军第四军医大学第一附属医院 | Epiderm specificity transfer factor |
| CN101444534A (en) * | 2008-12-15 | 2009-06-03 | 艾金长 | Psoriasis capsule |
| CN101843766A (en) * | 2009-10-28 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating psoriasis |
| CN102266435A (en) * | 2011-07-01 | 2011-12-07 | 张清林 | Traditional Chinese medicine for treating psoriasis |
| CN103463292A (en) * | 2013-09-25 | 2013-12-25 | 刘越泽 | Medicament for treating psoriasis |
-
2015
- 2015-04-13 CN CN201510171391.8A patent/CN104721807A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1019400B (en) * | 1985-07-22 | 1992-12-09 | 三和化工株式会社 | Method for manufacture of polyolefin foam |
| CN1259523A (en) * | 1999-08-31 | 2000-07-12 | 中国人民解放军空军总医院 | Immuno active polypeptide for treating psoriasis and its prepn. method |
| CN1319400A (en) * | 2001-02-28 | 2001-10-31 | 中国人民解放军第四军医大学第一附属医院 | Epiderm specificity transfer factor |
| CN101444534A (en) * | 2008-12-15 | 2009-06-03 | 艾金长 | Psoriasis capsule |
| CN101843766A (en) * | 2009-10-28 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating psoriasis |
| CN102266435A (en) * | 2011-07-01 | 2011-12-07 | 张清林 | Traditional Chinese medicine for treating psoriasis |
| CN103463292A (en) * | 2013-09-25 | 2013-12-25 | 刘越泽 | Medicament for treating psoriasis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103566243A (en) | Traditional Chinese medicine for treating dyspepsia | |
| CN106473140A (en) | A kind of gastrodia tuber health nutritive powder | |
| CN104873826A (en) | Tea drink capable of clearing away lung heat and dispelling damp and preparation method thereof | |
| CN104605387A (en) | Nutritional herbal cuisine capable of relieving postoperation radiotherapy response of cancer patient | |
| CN105168799A (en) | Medicine for treating bacillary white diarrhea and preparation method thereof | |
| CN104605372A (en) | Nutritional herbal cuisine based on cancer radiotherapy patient and preparation method thereof | |
| CN103272147B (en) | Traditional Chinese medicine preparation for curing vomiting of pregnancy | |
| CN104721807A (en) | Oral liquid for treating psoriasis | |
| CN105250747A (en) | Health maintenance paste | |
| CN104524358A (en) | Pills for adjuvant treatment of iron-deficiency anemia and preparation method thereof | |
| CN104161857A (en) | Traditional Chinese medicine for treating heart-kidney yin deficiency symptom-type coronary heart disease | |
| CN103251840B (en) | Veterinary traditional Chinese medicine for tonifying qi and strengthening exterior | |
| CN105902766A (en) | Peptic ulcer treating medicine and preparation method thereof | |
| CN105169035A (en) | Enema for treating acute infantile diarrhea and preparation method | |
| CN105998469A (en) | Traditional Chinese medicine preparation for treating hypersomnia and preparation method | |
| CN105663483A (en) | Traditional Chinese medicine composition for treating parasitic malnutrition type iron deficiency anemia and preparation method thereof | |
| CN104689249A (en) | Medicine used for nursing and treating qi-blood deficiency burn and preparing method thereof | |
| CN104189576A (en) | Traditional Chinese medicine preparation for treating summer sunburn | |
| CN113398202A (en) | A Chinese medicinal composition with kidney invigorating effect, and its preparation method | |
| CN105435027A (en) | Traditional Chinese medicine composition treating osseous tuberculosis | |
| CN105477566A (en) | Traditional Chinese medicine preparation for weight loss and detoxification | |
| CN104189308A (en) | Wine for relaxing tendons, clearing damp and relieving pain | |
| CN103638188A (en) | Chinese medicine for preventing and treating chronic osteomyelitis and preparation method thereof | |
| CN112353872A (en) | Preparation method of compound preparation and application of compound preparation in preparation of medicine for preventing or treating sleep disorder | |
| CN110893230A (en) | Traditional Chinese medicine composition for improving immunity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150624 |
|
| RJ01 | Rejection of invention patent application after publication |